Home › High Blood Pressure › Tennessee › Chattanooga
High Blood Pressure clinical trials in Chattanooga, TN
3 studies for High Blood Pressure are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
RecruitingPhase 2
- Chattanooga Research & Medicine CHARM, Chattanooga
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Chattanooga
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Chattanooga
- Clinical Trial Site, Chattanooga
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Birmingham, AL11 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Metastatic Cancer6 studies
- Myasthenia Gravis6 studies
- Ovarian Cancer5 studies
- Diabetes4 studies
- Steatotic Liver Disease4 studies
- Melanoma4 studies
- Ischemic Stroke4 studies
- Colorectal Cancer4 studies
- Chronic Kidney Disease4 studies
- Lung Cancer4 studies
- Kidney Failure3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.